Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NC-ND 4.0Nature Communications

The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer

49 more authors

60 listed; 61 in total.

Related

  1. Pancreatic acinar cell carcinoma demonstrates marked clinical heterogeneity and recurrent actionable genomic alterations
    Noor Farhoud, Raed Al-Rajabi, Joaquina Baranda +15
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Serum [-2]proPSA as a Candidate Phenotypic Correlate of Molecular Alterations and Prognostic Marker in Metastatic Castration-Resistant Prostate Cancer.
    Vincenza Conteduca, Marianna Garofoli, Giuseppina Bruno +5
    Prostate cancerPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
    Jane McKenzie, Lauren Howard, Joseph J. Park +13
    Prostate Cancer and Prostatic DiseasesPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. Reclassifying No Specific Molecular Profile Endometrial Cancer: A Narrative Review of Molecular Heterogeneity, Prognostic Refinement, and Clinical Management
    Yujing You, Yan Zhang
    CancersPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  5. Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data.
    Dimitrios Diamantidis, Georgios Tsakaldimis, Nikolaos Smyrlis +10
    Current urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
BibTeX
@article{pellegrina2026molecular,
  title = {{The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer}},
  author = {Diogo Pellegrina and Daria Kiriy and Kevin C. L. Cheng and Francesco Favero and Enrichetta Miletti and Zoe P. Klein and Barbara Hernando and Andre V. Olsen and Atef Sahli and Yunfan Fu and Pavlo Lutsik and Weerachai Jaratlerdsiri and William J. Hutchison and G. Steven Bova and Daniel S. Brewer and Mark Brook and Benedikt Brors and Adam Butler and Géraldine Cancel-Tassin and Niall M. Corcoran and Olivier Cussenot and Abraham Gihawi and Etsehiwot G. Girma and Vincent J. Gnanapragasam and Anis A. Hamid and Housheng Hansen He and Eddie Luidy L. Imada and G. Maria Jakobsdottir and Chol-hee Jung and Francesca Khani and Zsofia Kote-Jarai and Philippe Lamy and Gregory Leeman and Massimo Loda and Ramyar Molania and Lucio R. Queiroz and Tobias Rausch and Brian Robinson and Karina D. Sørensen and Sebastian Uhrig and Yaobo Xu and Takafumi N. Yamaguchi and Claudio Zanettini and Pan Prostate Cancer Group and Stefano Mangiola and Lena Voith von Voithenberg and Luigi Marchionni and Anthony T. Papenfuss and Bernard Pope and Vanessa M. Hayes and Thorsten Schlomm and Robert G. Bristow and Christopher M. Hovens and Ros A. Eeles and Colin S. Cooper and Clarissa Gerhauser and Geoff Macintyre and Andreas J. Gruber and David C. Wedge and Joachim Weischenfeldt},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-77900-7},
  url = {https://www.nature.com/articles/s41467-026-77900-7},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer
AU  - Diogo Pellegrina
AU  - Daria Kiriy
AU  - Kevin C. L. Cheng
AU  - Francesco Favero
AU  - Enrichetta Miletti
AU  - Zoe P. Klein
AU  - Barbara Hernando
AU  - Andre V. Olsen
AU  - Atef Sahli
AU  - Yunfan Fu
AU  - Pavlo Lutsik
AU  - Weerachai Jaratlerdsiri
AU  - William J. Hutchison
AU  - G. Steven Bova
AU  - Daniel S. Brewer
AU  - Mark Brook
AU  - Benedikt Brors
AU  - Adam Butler
AU  - Géraldine Cancel-Tassin
AU  - Niall M. Corcoran
AU  - Olivier Cussenot
AU  - Abraham Gihawi
AU  - Etsehiwot G. Girma
AU  - Vincent J. Gnanapragasam
AU  - Anis A. Hamid
AU  - Housheng Hansen He
AU  - Eddie Luidy L. Imada
AU  - G. Maria Jakobsdottir
AU  - Chol-hee Jung
AU  - Francesca Khani
AU  - Zsofia Kote-Jarai
AU  - Philippe Lamy
AU  - Gregory Leeman
AU  - Massimo Loda
AU  - Ramyar Molania
AU  - Lucio R. Queiroz
AU  - Tobias Rausch
AU  - Brian Robinson
AU  - Karina D. Sørensen
AU  - Sebastian Uhrig
AU  - Yaobo Xu
AU  - Takafumi N. Yamaguchi
AU  - Claudio Zanettini
AU  - Pan Prostate Cancer Group
AU  - Stefano Mangiola
AU  - Lena Voith von Voithenberg
AU  - Luigi Marchionni
AU  - Anthony T. Papenfuss
AU  - Bernard Pope
AU  - Vanessa M. Hayes
AU  - Thorsten Schlomm
AU  - Robert G. Bristow
AU  - Christopher M. Hovens
AU  - Ros A. Eeles
AU  - Colin S. Cooper
AU  - Clarissa Gerhauser
AU  - Geoff Macintyre
AU  - Andreas J. Gruber
AU  - David C. Wedge
AU  - Joachim Weischenfeldt
PY  - 2026
DA  - 2026/10/16
JO  - Nature Communications
DO  - 10.1038/s41467-026-77900-7
UR  - https://www.nature.com/articles/s41467-026-77900-7
SN  - 2041-1723
ER  -